TGFβ1 behaves as a tumor promoter in late-stage tumorigenesis by increasing angiogenesis, metastasis, and epithelial-mesenchymal-transition (EMT) [44], therefore, the downregulation of TGFβ1 led to the inhibition of cancer cell proliferation. Here, TGFB1 is linked to neoplasm.